PF-Atlas › Clinical Trials › NCT01257464
Sitagliptin in Cystic Fibrosis-Related Diabetes
Sitagliptin · Phase 2
Registry ID
NCT01257464
Phase
Phase 2
Status
Terminated
Drug / intervention
Sitagliptin
Sponsor
University of British Columbia
Start
2010-09
About this trial
Sitagliptin is evaluated in NCT01257464, a Phase 2 idiopathic pulmonary fibrosis study sponsored by University of British Columbia. Current status: Terminated.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT01257464 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.